# Dexmedetomidine as an Adjuvant for Femoral Nerve Block and Functional Recovery After Total Knee Arthroplasty

> **NCT04642651** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 170 (actual)

## Conditions studied

- Elderly
- Total Knee Arthroplasty
- Femoral Nerve Block
- Dexmedetomidine
- Functional Outcome

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04642651
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-25
- **Primary completion:** 2021-11-22
- **Final completion:** 2022-02-25
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2022-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04642651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04642651, "Dexmedetomidine as an Adjuvant for Femoral Nerve Block and Functional Recovery After Total Knee Arthroplasty". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT04642651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*